GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Scaled Net Operating Assets : -0.41 (As of Jun. 2023)

View and export this data going back to 2001. Start your Free Trial

What is GlaxoSmithKline Consumer Nigeria Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

GlaxoSmithKline Consumer Nigeria's operating assets for the quarter that ended in Jun. 2023 was ₦9,065 Mil. GlaxoSmithKline Consumer Nigeria's operating liabilities for the quarter that ended in Jun. 2023 was ₦21,054 Mil. GlaxoSmithKline Consumer Nigeria's Total Assets for the quarter that ended in Dec. 2022 was ₦29,386 Mil. Therefore, GlaxoSmithKline Consumer Nigeria's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2023 was -0.41.

GlaxoSmithKline Consumer Nigeria Scaled Net Operating Assets Historical Data

The historical data trend for GlaxoSmithKline Consumer Nigeria's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Consumer Nigeria Scaled Net Operating Assets Chart

GlaxoSmithKline Consumer Nigeria Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.21

0.46

-0.10

-0.07

-0.32

GlaxoSmithKline Consumer Nigeria Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23
Scaled Net Operating Assets	Get a 7-Day Free Trial															-	-0.07	-0.26	-0.30	-0.41

Competitive Comparison of GlaxoSmithKline Consumer Nigeria's Scaled Net Operating Assets

For the Drug Manufacturers - General subindustry, GlaxoSmithKline Consumer Nigeria's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GlaxoSmithKline Consumer Nigeria's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Consumer Nigeria's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where GlaxoSmithKline Consumer Nigeria's Scaled Net Operating Assets falls into.

GlaxoSmithKline Consumer Nigeria Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

GlaxoSmithKline Consumer Nigeria's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2022 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2022 )
=	(Operating Assets (A: Dec. 2022 )	-	Operating Liabilities (A: Dec. 2022 ))	/	Total Assets (A: Dec. 2021 )
=	(11385.333	-	19853.752)	/	26252.732
=	-0.32

where

	Operating Assets		(A: Dec. 2022 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	29386.204	-	18000.871
=	11385.333

	Operating Liabilities		(A: Dec. 2022 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	19853.752	-	0	-	0
=	19853.752

GlaxoSmithKline Consumer Nigeria's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jun. 2023 )
=	(Operating Assets (Q: Jun. 2023 )	-	Operating Liabilities (Q: Jun. 2023 ))	/	Total Assets (Q: Dec. 2022 )
=	(9064.684	-	21053.574)	/	29386.204
=	-0.41

where

	Operating Assets		(Q: Jun. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	30268.016	-	21203.332
=	9064.684

	Operating Liabilities		(Q: Jun. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	21053.574	-	0	-	0
=	21053.574

GlaxoSmithKline Consumer Nigeria Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Consumer Nigeria's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Consumer Nigeria PLC (NSA:GLAXOSMITH) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1, Industrial Avenue, Ilupeju, P.M.B. 21218, Ikeja, GSK House, Lagos, NGA

Website

https://www.ng.gsk.com

GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company has two reportable segments, the Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines, and nutritional healthcare; and the Pharmaceuticals segment consisting of vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, and others. The generates maximum revenue from the Pharmaceuticals segment.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Headlines

No Headlines